MucoLife Therapeutics

Private

GothenburgHealthcare & Life Scienceshttps://mucolife.com/

Last Round

Accelerator

Sep 6, 2024

Total Funding Raised

$30,000

Company Overview

MucoLife Therapeutics is a biotechnology company developing inhaled therapies for pulmonary mucus obstruction in chronic lung diseases such as COPD and cystic fibrosis.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

inhaled mucolyticmuco-obstructive lung diseaseCOPDcystic fibrosisfirst-in-class therapyrespiratory therapeuticsCFchronic obstructive pulmonary diseasepreclinical biotechairway clearancedrug developmentmucin biologypharma licensingnebulizer deliveryuniversity spin-outbronchiectasisasthma

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

MucoLife Therapeutics Comps

Public and private peers based on sector, stage, and business model.

MucoLife Therapeutics comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

MucoLife Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Accelerator	Sep 6, 2024

View all Funding Rounds

Key People

Founding team and executive leadership

Thaher Pelaseyed

Chief Executive Officer

Executive Team

MucoLife Therapeutics Investors

Notable investors and investment history

MucoLife Therapeutics investors
Investor	Rounds
Vasa Angels I	Accelerator

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Sep 6, 2024
$30K round led by Health Wildcatters

View all signals

MucoLife Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

MucoLife Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about MucoLife Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersGothenburg

Employee Range1

Year Founded2023

Last FundingSep 6, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.